Abstract
We investigated changes in the secretory kinetics of gastric endocrine cells related to the administration of lansoprazole, and the effects of enprostil on these altered kinetics. Male Wistar-derived 8-week-old rats were allotted to a control group, a lansoprazole administration group, an enprostil administration group, and a lansoprazole + enprostil administration group. Lansoprazole (30 mg/kg once a day for 4 weeks) and enprostil (10μg/kg twice a day for 4 weeks) were administered into the gastric lumen with a gastric tube. At this time, blood was collected and immunohistological staining of gastric endocrine cells was conducted to investigate the secretory kinetics. Lansoprazole administration induced hypergastrinemia, increase of gastrin cells, and increase of enterochromaffin-like cells. Enprostil administration induced increase of somatostatin cells. The group administered lansoprazole + enprostil exhibited significant decreases in serum gastrin level, total gastrin cell count, and total enterochromaffin-like cell count, compared with the group administered lansoprazole alone. These findings suggest that enprostil may ameliorate the alteration in gastric endocrine secretion produced by the chronic administration of lansoprazole.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Axelson J, Håkanson R, Rossengren E, et al. Hypergastrinaemia induced by acid blockade evokes enterotrochromaffin-like (ECL) cell hyperplasia in chicken, hamster and guinea-pig stomach. Cell Tissue Res 1988;254:511–516.
Ryberg B, Bishop AE, Bloom SR, et al. Omeprazole and ranitidine, antisecretagogues with different modes of action, are equaly effective in causing hyperplasia of enterochromaffin-like cells in rat stomach. Regul Pept 1989;25:235–246.
Ekman L, Hansson E, Havu N, et al. Toxicological studies on omeprazol. Scand J Gastroenterol 1985;20(Suppl 108):53–69.
Giraud AS, Walsh JH, Soll AH. Prostanoids of the PGE2 series differentially affect gastrin (G) release from canine G cell in short term culture. Gastroenterology 1986;90:1428.
Schepp W, Chan CB, Giraud AS, et al. Effects of prostaglandins on gastrin release from canine antral mucosal cells in primary culture. Am J Physiol 1994;266:G194-G200.
Meijer JL, Jansen JB, Biemond I, et al. Effect of enprostil on serum gastrin and pepsinogen A and C levels in patients on long-term treatment with omeprazole. Aliment Pharmacol Ther 1994;8:221–227.
Omura N, Kashiwagi H, Aoki T. Changes in gastric hormones associated with gastric outlet obstruction. An experimental study in rats. Scand J Gastroenterol 1993;28:568–572.
Creutzfeldt W, Lamberts R, Stockmann F, et al. Quantitative studies of gastric endocrine cells in patients receiving long-term treatment with omeprazole. Scand J Gastroenterol Suppl 1989;166:122–128.
Håkanson R, Chen D, Sundler F. The ECL cells. In: Johnson JR (ed) Physiology of the gastrointestinal tract. New York: Raven, 1994;1171–1184.
Omura N, Kashiwagi H, Aoki T. Effect of famotidine on gastrin cell, somatostatin cell, and prostaglandin E2 concentration of stomach in experimental pyloric stenosis model (in Japanese with English abstract). Nippon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol) 1992;89:2754–2761.
Satoh H, Inatomi N, Nagaya H, et al. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. J Pharmacol Exp Ther 1989;248:806–815.
Takemura J, Seino Y, Nishi S, et al. Effects of prostaglandin E2 and D2 on gastric somatostatin and gastrin secretion. Regul Pept 1983;6:379–384.
Uribe A, Grimelius L, Theodorsson LE, et al. Oral E2 prostaglandins affect endocrine cell populations in the gastric antrum of the rat. Eur J Clin Invest 1989;19:146–153.
Svendsen LB, Stener JF, Larsen JK. Influence of the prostaglandin E1 analogue rinoprostil on the human gastric mucosa. Digestion 1987;37:29–34.
Meijer JL, Crobach LFSJ, Jansen JBMJ, et al. Effect of synthetic prostaglandin E2 analog enprostil on omeprazol-induced hypergastrinemia and hyperpepsinogenemia. Dig Dis Sci 1994;39:609–616.
Wong AG, Turke ML, Perry MR, et al. The gastric antisecretory profile of enprostil. Proc West Pharmacol Soc 1989;32:49–56.
Watanabe M. Effects of prostaglandin E1 and E2 on the changes of gastric endocrine kinetics induced by long-term administration of histamine H2 receptor antagonist in rats (in Japanese with English abstract). Tokyo Jikeikai Ikadaigaku Zasshi (Tokyo Jikeikai Med J) 1996;111:645–657.
Schubert ML, Edwards NF, Arimura, et al. Paracrine regulation of gastric secretion by fundic somatostatin. Am J Physiol 1987;252:G485-G490.
Jewell LD, Yacoub W, Salkie ML, et al. Enprostil reduces G-cell hyperplasia and hypergastrinemia in duodenal ulcer. Clin Ther 1987;9:281–295.
Crean GP, Marshall MW, Rumsey RDE. Parietal cell hyperplasia induced by the administration of pentagastrin (ICI 50,123) to rats. Gastroenterology 1969;57:147–155.
Tielemans Y, Håkanson R, Sundler F, et al. Proliferation of enterochromaffin-like cells in omeprazole-treated hypergastrinemic rats. Gastroenterology 1989;96:723–729.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Omura, N., Kashiwagi, H., Aoki, T. et al. Effects of enprostil on gastric endocrine secretion during chronic administration of lansoprazole. J Gastroenterol 32, 740–746 (1997). https://doi.org/10.1007/BF02936949
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02936949